JOHN H ABELES Insider Trading $DUSA DUSA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN H ABELES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN H ABELES. JOHN H ABELES is in Medite Cancer Diagnostics, Inc. ($MDIT) and Director in ORYX TECHNOLOGY CORP ($ORYX) and Director in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in Neurotrope, Inc. ($NTRP).
JOHN H ABELES in DUSA PHARMACEUTICALS INC
Trading Symbol: DUSAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN H ABELES: Director
Holdings: 77,000 shares
Latest Transaction: Jul 01 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN H ABELES in DUSA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DUSA, MDIT, NTRP, ORYX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2010 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 2.15 | 10,000 | 21,500 | 10,000 | |
Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 1.30 | 20,000 | 25,960 | 77,000 | 57 K to 77 K (+35.09 %) |
Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 1.26 | 20,000 | 25,120 | 57,000 | 37 K to 57 K (+54.05 %) |
Jul 01 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 1.10 | 10,000 | 11,000 | 10,000 | |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Grant | A | 0.00 | 7,500 | 0 | 12,500 | 5 K to 12.5 K (+150.00 %) |
Jul 01 2008 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 2.01 | 10,000 | 20,100 | 10,000 | |
Nov 14 2007 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | P | 2.05 | 5,000 | 10,250 | 114,500 | 109.5 K to 114.5 K (+4.57 %) |
Jul 02 2007 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 3.08 | 10,000 | 30,800 | 10,000 | |
Jul 05 2006 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 5.65 | 10,000 | 56,500 | 10,000 | |
Jul 01 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 9.30 | 10,000 | 93,000 | 10,000 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | M | 6.94 | 10,000 | 69,375 | 0 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | M | 2.51 | 10,000 | 25,100 | 0 | |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Sell | S | 15.00 | 10,000 | 150,030 | 10,000 | 20 K to 10 K (-50.00 %) |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | M | 6.94 | 10,000 | 69,375 | 20,000 | 10 K to 20 K (+100.00 %) |
Jan 20 2005 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Buy | M | 2.51 | 10,000 | 25,100 | 10,000 | 0 to 10 K |
Jul 01 2004 | DUSA | DUSA PHARMACEUTICA ... | ABELES JOHN H | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 |
Page: 1